US boost for cannabis-based epilepsy medicine

April 14, 2015 7:27 AM

7 0

US boost for cannabis-based epilepsy medicine

Cambridge based GW Pharmaceuticals, which is commercialising cannabis-based medicines across a broad disease range on both sides of the Atlantic, has received a boost in the US.

It came in the form of encouraging data on GW’s investigational medicine Epidiolex issued by the American Academy of Neurology (AAN).

Read more

To category page

Loading...